The FDA has approved nivolumab (Opdivo) plus AVD as first-line treatment for advanced classical Hodgkin lymphoma in patients ...
Phase 3 TALAPRO-3 results show that talazoparib plus enzalutamide significantly improves radiographic progression-free survival in HRR-mutated metastatic castration-sensitive prostate cancer, ...
The Phase 2 FOURLIGHT-1 trial shows that atirmociclib plus fulvestrant significantly improves progression-free survival in HR+, HER2- metastatic breast cancer after CDK4/6 inhibitors, reducing ...
Vergent Bioscience has launched the Phase 3 VISUALIZE 2 trial evaluating abenacianine, a tumor-activated imaging agent designed to enhance intraoperative tumor detection in lung cancer surgery. The ...
Researchers developed a CAR-T manufacturing strategy using the cytokine fusion scaffold HCW9206 to generate longer-lasting ...
Results from the phase 3 RECITE trial show that romiplostim significantly reduces chemotherapy-induced thrombocytopenia, ...
A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...
A nationwide U.S. study published in JAMA, analyzing data from 2.15 million women with breast cancer, found that choosing complementary and alternative medicine (CAM) instead of evidence-based therapy ...
New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
The FDA has approved the Altius® System, an innovative device for managing chronic pain in lower limb amputees. Utilizing direct electrical nerve stimulation, the device proved effective in reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results